ABUS — ARBUTUS BIOPHARMA CORP

Ownership history in Western Standard LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which Western Standard LLC reported a position in ARBUTUS BIOPHARMA CORP (ABUS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.13% (2025 Q4)
Avg. % of fund
0.91%
First filed
2025 Q3
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 507,853 — 0% 1.13% $2.4M $4.81
2025 Q3 INITIATED 507,853 — — 0.68% $2.3M $4.54
% of Fund (quarterly)    ABUS price (monthly, adj. close)

Other funds also holding ABUS

As of 2025 Q4 — sorted by position size

Whitefort Capital Management, LP 3Y 16.41% Rangeley Capital, LLC 3.36% ADAR1 Capital Management, LLC 1.89% Two Seas Capital LP 3Y 1.25% STEMPOINT CAPITAL LP 0.81% BlackBarn Capital Partners LP 0.59% SHERBROOKE PARK ADVISERS LLC 3Y 0.35% AlphaCentric Advisors LLC 3Y 0.23% Murchinson Ltd. 3Y 0.21% Exome Asset Management LLC 0.17%
← Back to Western Standard LLC Holdings